Pediatrician Office Drug Prevention

描述（由申请人提供）：拟议的第一阶段SBIR项目将证明开发一个药物预防模块的可行性，该模块可以通过儿科医生办公室托管。该干预措施将帮助青少年（11-15岁）的父母预防门户药物的发作，包括酒精，烟草，大麻和吸入剂。该计划将通过CHADIS托管，这是一个可供儿科医生办公室使用的订阅门户网站。该模块将包括：（1）对父母及其青少年子女进行访视前筛查调查;（2）数据驱动的风险诊断;（3）以临床医生为中心的指导，为父母选择风险适当的教育材料;（4）父母教育组成部分。在第一阶段，将开发和试点测试诊断算法和原型家长教育材料的原型版本。该方案将侧重于11个共同的要素，以前评估的父母方案，以防止吸毒。这些包括帮助父母为不当行为提供适当的纪律，为可接受的行为建立界限，并为不可接受的行为定义限制，注意并加强积极的行为，有效地传达亲社会规范，价值观和期望，提供监督，监视朋友，活动和行踪，表现出温暖，给予社会支持，建立情感依恋，分享质量时间在一起，并成功地解决冲突。一期工程将重点完成五项任务。(1)我们将进行访问前评估。一系列调查将评估青少年的风险状况，了解父母养育子女的长处和短处。调查将不考虑那些需要对药物使用障碍进行临床治疗的青年。在那些没有被排除在外的人中，调查将评估青少年使用入门药物风险的有效标志物。(2)我们将使用现有的数据集来开发精算风险算法，以估计使用精算方法的每种网关药物的个体青少年的风险。这些分析的目的是准确估计未来30天网关药物使用的概率。(3)我们将完成原型干预开发。我们将制定一系列新的关键活动，针对家庭预防吸毒的11个共同要素中的每一个要素。这将有助于家长改善其为人父母的态度和防止青少年吸毒的技能。(4)我们将开发一个原型医生办公室协议。这将使儿科医生和支持人员 成为父母干预的中介。(5)我们将完成可行性研究。本研究的目的是证明所有元素的功能， 设计，能够履行其预期作用，并被视为可接受。参与者将是20个家庭，他们的青少年接受儿科诊所的护理。青少年和父母将接受筛查。未来药物使用的精算估计将提供给儿科办公室。儿科医生会给家长开预防方案，家长们会集体测试所有的指导成分。从父母、青少年、医生和其他工作人员收集的干预后评估将评估干预功能、可用性和可接受性。

DESCRIPTION (provided by applicant): The proposed Phase I SBIR project will demonstrate the feasibility of developing a drug prevention module that can be hosted through pediatrician offices. The intervention will assist parents of adolescents (ages 11-15) prevent the onset of gateway drugs, including alcohol, tobacco, marijuana, and inhalants. The program will be hosted via CHADIS, a subscription web portal available to pediatrician offices. This module will include: (1) pre-visit screening surveys for both parents and their adolescent children; (2) data-driven risk diagnoses; (3) clinician-focused instructions for selecting risk-appropriate educationa materials for parents; and (4) parental education components. During Phase I, a prototype version of the diagnosis algorithm and prototypical parent education materials will be developed and pilot tested. The program will focus on 11 elements common to previously evaluated parenting programs for the prevention of drug use. These include helping parents provide appropriate discipline for misbehavior, establish boundaries for acceptable behavior and define restrictions for unacceptable behavior, attend to and reinforce positive behavior, effectively communicate prosocial norms, values and expectations, provide supervision, monitor friends, activities, and whereabouts, show warmth, give social support, build emotional attachments, share quality time together, and successfully resolve conflicts. The Phase I project will focus on completing five tasks. (1) We will develop a pre-visit assessment. A set of surveys will assess the risk-status of adolescents and understand the parenting strengths and weakness of parents. The survey will exclude from consideration those youth who have the need for clinical treatment for substance use disorders. Among those not excluded, the survey will then assess validated markers of a teen's risk for using gateway drugs. (2) We will use existing datasets to develop an actuarial risk algorithm to estimate an individual adolescent's risk for using each gateway drug using actuarial methods. The objective of these analyses is to accurately estimate the probability of future 30-day gateway drug use. (3) We will complete prototype intervention development. We will develop a new series of key activities that address each of the 11 common elements of family-based drug prevention. These will help parents improve their parenting attitudes and skills related to preventing drug use among their adolescents. (4) We will develop a prototype physician office protocol. This will allow pediatricians and support staff to be intermediaries in the delivery of the parenting intervention. (5) We will complete a feasibility study. The objective of this study will be to demonstrate that all elements function as designed, are capable of fulfilling their intended roles and are deemed acceptable. Participants will be 20 families whose adolescents are cared for by a pediatric practice. Adolescents and parents will be screened. Actuarial estimates of future drug use will be provided to the pediatric office. Pediatricians will prescribe the prevention program to parents who will collectively test al instructional components. Post intervention assessments gathered from parents, adolescents, physicians, and other staff will assess intervention functioning, usability, and acceptability.